[Diagnosis and satisfactory surgical treatment of a jejunal stromal tumor].
GIST is the most common mesenchymal tumor of the gastrointestinal tract. The discovery of KIT proto-oncogene mutations in the pathogenesis of this tumor, and the development of imatinib mesylate, a specific inhibitor of KIT tyrosine kinase function have revolutionized the treatment of GIST. We present the clinical case of a patient with an upper digestive bleeding secondary to a jejunal GIST. Therapeutic options are highlighted.
Marín-Gómez
L M
LM
Servicio de Cirugía General y del Aparato Digestivo, Hospital Universitario de Puerto Real, Puerto Real (Cádiz), Ctra. Nal. IV, Km. 665, España 11510. marinlm@hotmail.com
Vega-Ruiz
V
V
García-Ureña
M A
MA
Moreno García
M I
MI
D046152:Gastrointestinal Stromal Tumors / Q000175:diagnosis* / Q000601:surgery*; D006801:Humans; D007580:Jejunal Neoplasms / Q000175:diagnosis* / Q000601:surgery*; D008297:Male; D008875:Middle Aged; D000090063:Proto-Oncogene Mas